Original fundamental research starts and ENDS here.
Sectors Tags Blog
TMO
30 filings
Timeline Columns Start Research 8-K Categories
Earnings8 M&A4 Debt / Financing3 Executive Change3 Shareholder Meeting2
2025
Q4 5 filings
Dec
EUR Debt Offering
€2.1B notes issued (€1B floating 2027, €1.1B fixed 3.628% 2035)
8-K
Oct
Q3 2025 Results
Unable to extract revenue and EPS data from provided XBRL metadata
10-Q
Oct
Acquired Clario Holdings
$8.875B cash deal plus $525M contingent payments
8-K
Oct
Q3 2025 Earnings
Q3 2025 results for quarter ended Sept 27, 2025
8-K
Oct
Debt Offering
$2.5B notes issued, rates 4.2%-4.9%, maturities 2031-2037
8-K
Q3 4 filings
Sep
Acquired Solventum Purification Business
Completed acquisition of Solventum Corporation's purification and filtration business
8-K
Aug
Q2 2025 Results
Unable to extract financial data - document appears corrupted or improperly formatted
10-Q
Jul
CFO Succession
Stephen Williamson retiring March 31, 2026; James Meyer appointed CFO March 1, 2026
8-K
Jul
Q2 2025 Earnings
Financial results for quarter ended June 28, 2025
8-K
Q2 5 filings
May
Annual Shareholder Meeting
Executive compensation rejected 111M for vs 201M against
8-K
May
CEO Retention Award
$60M performance equity grant to CEO through 2030
8-K
May
Q1 2025 Results
Financial data not available in provided excerpt
10-Q
Apr
Q1 2025 Earnings
Financial results for quarter ended March 29, 2025
8-K
Apr
2025 Proxy Statement
2024 results: $42.88B revenue, $21.86 adj EPS, $7.3B FCF
DEF 14A
Q1 4 filings
Feb
Acquired Solventum Purification Unit
$4.1B cash deal, close by end 2025
8-K
Feb
FY24 2024 Results
Unable to extract specific revenue and EPS figures from provided XBRL metadata
📌 Company issued new senior notes with maturities ranging from 2028-2050, indicating continued debt refinancing activities
10-K
Feb
Board Expansion - New Director
Karen S. Lynch elected to Board, expanded to 12 members
8-K
Jan
Q4 2024 Earnings
Financial results for quarter and year ended Dec 31, 2024
8-K
2024
Q4 2 filings
Nov
Q3 2024 Results
Unable to extract specific revenue and EPS figures from provided XBRL data
10-Q
Oct
Q3 2024 Earnings
Q3 2024 financial results announced
8-K
Q3 3 filings
Aug
Q2 2024 Results
Unable to extract specific revenue and EPS figures from the provided XBRL data format
10-Q
Jul
Q2 Earnings
Financial results for quarter ended June 29, 2024
8-K
Jul
Olink Tender Offer Completed
Tender offer for Olink Holding AB expired and results announced
8-K
Q2 4 filings
May
Annual Shareholder Meeting
11 directors elected, executive compensation approved, majority voting proposal rejected
8-K
May
Q1 2024 Results
Unable to extract revenue and EPS data from provided filing content
10-Q
Apr
Q1 2024 Earnings
Q1 2024 financial results announced
8-K
Apr
2024 Proxy Statement
Revenue: $42.86B, Adj EPS: $21.55, Free cash flow: $7.01B
DEF 14A
Q1 2 filings
Feb
FY2023 2023 Results
Unable to extract specific revenue and EPS figures from provided XBRL metadata
📌 Completed acquisitions of The Binding Site Group (January 2023), CorEvitas LLC (August 2023), and Olink Holding AB (October 2023) to expand specialty diagnostics and laboratory capabilities
10-K
Jan
Q4 2023 Earnings
Financial results for fiscal quarter and year ended Dec 31, 2023
8-K
2023
Q4 1 filings
Dec
Debt Offering
$2.5B notes issued: $1B 5.000% 2026, $1B 5.000% 2029, $500M 5.200% 2034
8-K
SECENDS is not affiliated with the SEC. Data from public EDGAR filings. Not financial advice.